Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
-
Narrated by:
-
By:
Summary
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.
adbl_web_anon_alc_button_suppression_c
No reviews yet